Upload
angra-mainyu
View
225
Download
0
Embed Size (px)
Citation preview
7/29/2019 20121120 UNAIDS Global Report 2012 En
1/110
GLOBALRepORt
UNAIDS RepoRt oN theglobAl AIDS epIDemIc | 2012
7/29/2019 20121120 UNAIDS Global Report 2012 En
2/110
Copyright 2012Joint United Nations Programme on HIV/AIDS (UNAIDS)
All rights reserved
The designations employed and the presentation of the material in this publication do not imply t he expression of any
opinion whatsoever on the part of UNAIDS concerning the legal status of any country, territory, city or area or of itsauthorities, or concerning the delimitation of its f rontiers or boundaries. UNAIDS does not warrant that the information
published in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use.
WHO Library Cataloguing-in-Publication Data
Global report: UNAIDS report on the global AIDS epidemic 2012
UNAIDS / JC2417E
1.HIV infections therapy. 2.HIV infections diagnosis. 3.HIV infections epidemiology.4.Acquired immunodeficiency syndrome prevention and control. 5.International cooperation. I.UNAIDS.
ISBN 978-92-9173-996-7 (Printed version) (NLM classification: WC 503.6)ISBN 978-92-9173-592-1 (Digital version)
7/29/2019 20121120 UNAIDS Global Report 2012 En
3/110
globAl RepoRt
UNAIDS RepoRt oN theglobAl AIDS epIDemIc | 2012
7/29/2019 20121120 UNAIDS Global Report 2012 En
4/110
7/29/2019 20121120 UNAIDS Global Report 2012 En
5/110
FoReWoRD 4
INtRoDUctIoN 6
StAte oF the epIDemIc 8
tARget 1 Sexual transmission 16
tARget 2 People who inject drugs 34
tARget 3 HIV infection among children and keeping their mothers alive 42
tARget 4 Treatment 50
tARget 5 Tuberculosis and HIV 58
tARget 6 Resources and spending 62
tARget 7 Gender and the HIV response 70
tARget 8 Stigma, discrimination and the law 78
tARget 9 Eliminating restrictions on entry, stay and residence 86
tARget 10 Integration 90
ReFeReNceS 96
contents
7/29/2019 20121120 UNAIDS Global Report 2012 En
6/1104
UNAIDS
Foreword
7/29/2019 20121120 UNAIDS Global Report 2012 En
7/1105
2012 GLOBAL REPORT
Te progress highlighted in this report will inspire hope around the world. Countries
continue to achieve dramatic results in the AIDS response in lives saved and new
inections averted.
Even as the global economic recovery remains uncertain, our vision o getting to zero new
HIV inections, zero discrimination and zero AIDS-related deaths remains high on the
international agenda. Te data presented here indicates that countries are keeping their
commitments to reach the targets o the 2011 United Nations Political Declaration onHIV and AIDS.
Te pace o progress has quickened. Increments o achievement that once stretched over
many years are now being reached in ar less time. In just 24 months, 60% more people
have accessed liesaving HIV treatment, with a corresponding drop in mortality. New
inection rates have allen by 50% or more in 25 countries 13 o them in in sub-Saharan
Arica. Hal o all the reductions in HIV inections in the past two years have been among
children; this has emboldened our conviction that achieving an AIDS-ree generation is
not only possible, but imminent.
Yet, it is much too early to congratulate ourselves. AIDS is not over. Te data in this report
provided by a record 186 UN Member States, indicate that in many countries, people living
with and aected by HIV still ace stigma, discrimination and injustice. Women and girls
are still at higher risk because o gender inequity and sexual violence. Tere is still a 30% gap
between resources that are available and what is needed annually by 2015.
Tere are around 1000 days until the deadline or achieving the 2015 AIDS targets. Every
one o the next 1000 days will be a test o our commitment to bring an end to this epidemic.
We count on all partners globally, regionally and in countries to unite in advancing the
AIDS response and delivering breakthrough results or people. Our targets are in sight.
Michel Sidib
UNAIDS Executive Director
Under Secretary-General o the United Nations
7/29/2019 20121120 UNAIDS Global Report 2012 En
8/1106
UNAIDS
IntrodUctIon
Te global community has embarked on an historic quest to lay the oundation orthe eventual end o the AIDS epidemic.
Tis eort is more than merely visionary. It is entirely easible. Unprecedented gains
have been achieved in reducing the number o both adults and children newly inected
with HIV, in lowering the numbers o people dying rom AIDS-related causes and in
implementing enabling policy rameworks that accelerate progress. A new era o hope
has emerged in countries and communities across the world that had previously been
devastated by AIDS.
However, a world in which AIDS has been eliminated can only be achieved throughrenewed and sustained commitment and solidarity and only i the available evidence
and limited resources are used as eciently and eectively as possible.
Recognizing the genuine opportunity to plan or the end o AIDS, countries pledged
in the 2011 United Nations Political Declaration on HIV and AIDS: Intensiying Our
Eorts to Eliminate HIV and AIDS (1) to take specic steps to achieve ambitious
goals by 2015. Drawing rom the 2011 Political Declaration, UNAIDS has articulated
10 specic targets or 2015 to guide collective action.
1.Reduce sexual transmission by 50%.
2. Reduce HIV transmission among people who inject drugs by 50%.
3. Eliminate new inections among children and substantially reduce the number omothers dying rom AIDS-related causes.
4. Provide antiretroviral therapy to 15 million people.
5. Reduce the number o people living with HIV who die rom tuberculosis by 50%.
6. Close the global AIDS resource gap and reach annual global investment o US$22 billion to US$ 24 billion in low- and middle-income countries.
7. Eliminate gender inequalities and gender-based abuse and violence and increasethe capacity o women and girls to protect themselves rom HIV.
8.
Eliminate stigma and discrimination against people living with and aected byHIV by promoting laws and policies that ensure the ull realization o all humanrights and undamental reedoms.
9. Eliminate restrictions or people living with HIV on entry, stay and residence.
10. Eliminate parallel systems or HIV-related services to strengthen the integrationo the AIDS response in global health and development eorts.
7/29/2019 20121120 UNAIDS Global Report 2012 En
9/1107
2012 GLOBAL REPORT
In embracing the targets in the 2011 Political Declaration, countries committed to
monitor and report on progress and challenges encountered in their national AIDS
responses. o acilitate biennial reporting on national progress, UNAIDS collaborated
with partners to develop a set o core indicators against which countries would report (2).
In 2012, 186 countries submitted comprehensive reports on progress in their national
AIDS response. With 96% o the 193 United Nations Member States reporting in 2012,
the Global AIDS Response Progress Reporting system has among the highest response
rates o any international health and development monitoring mechanism a vivid
reection o the breadth and depth o global commitment to the response to AIDS.
Drawing on inormation provided by countries, this report summarizes the current
situation in the eort to reach the 2015 targets set orth in the 2011 Political
Declaration. In addition to providing a snapshot o the current situation or each
target, it identies key trends. Using a scorecard approach on key indicators, the report
allows individual countries to compare their own achievements with those o others.
Regional breakdowns enable comparison o progress between dierent parts o the
world. Tis report highlights instances where recommended policies and programmes
have yet to be implemented.
As part o global AIDS response monitoring, countries have completed extensive surveys
on national AIDS policy rameworks. Te National Commitments and Policies Instrument
obtains inormation on the process o national strategizing on AIDS, engagement o civil
society and other key constituencies as well as policy approaches or HIV prevention and
treatment.
Te results summarized here are encouraging, since progress achieved to date
conclusively demonstrates the easibility o achieving the targets set in the 2011
Political Declaration. However, the ndings also reveal that, to reach most o those
targets by 2015, a signicant additional eort is required.
186coUNtRIeS RepoRtINg
In 2012, 186 untris
sumittd mrnsiv
rrts n tir natina
AIDS rsns: 96% UN
Mmr Stats.
Introduction
7/29/2019 20121120 UNAIDS Global Report 2012 En
10/1108
UNAIDS
stAte oF tHe ePIdeMIc
Although AIDS remains one o the worlds most serious health challenges, global
solidarity in the AIDS response during the past decade continues to generate
extraordinary health gains. Historic success in bringing HIV programmes to scale
combined with the emergence o powerul new tools to prevent people rom
becoming inected and rom dying rom AIDS-related causes has enabled the
oundation to be laid or the eventual end o AIDS.
Although much o the news on AIDS is encouraging, challenges remain. Te
number o people newly inected globally is continuing to decline, but national
epidemics continue to expand in many parts o the world. Further, declines in the
numbers o children dying rom AIDS-related causes and acquiring HIV inection,although substantial, need to be accelerated to achieve global AIDS targets.
The globAl epIDeMIc AT A glANce
Globally, 34.0 million [31.4 million35.9 million] people were living with HIV at the
end o 2011. An estimated 0.8% o adults aged 15-49 years worldwide are living with
HIV, although the burden o the epidemic continues to vary considerably between
countries and regions.
Sub-Saharan Arica remains most severely aected, with nearly 1 in every 20 adults
(4.9%) living with HIV and accounting or 69% o the people living with HIV
worldwide. Although the regional prevalence o HIV inection is nearly 25 times
higher in sub-Saharan Arica than in Asia, almost 5 million people are living with
HIV in South, South-East and East Asia combined. Afer sub-Saharan Arica, the
regions most heavily aected are the Caribbean and Eastern Europe and Central
Asia, where 1.0% o adults were living with HIV in 2011.
New INfecTIoNS DeclININg
Worldwide, the number o people newly inected continues to all: the number
o people (adults and children) acquiring HIV inection in 2011 (2.5 million [2.2
million2.8 million]) was 20% lower than in 2001. Here, too, variation is apparent.
Te sharpest declines in the numbers o people acquiring HIV inection since 2001
have occurred in the Caribbean (42%) and sub-Saharan Arica (25%).
7/29/2019 20121120 UNAIDS Global Report 2012 En
11/1109
2012 GLOBAL REPORT
State o the epidemic
ga hIV trnds, 19902011
High estimate
Estimate
Low estimate
NUmbeR oF people lIvINg WIth hIv, globAl, 19902011
NUmbeR oF people NeWly INFecteD WIth hIv, globAl, 19902011
ADUlt AND chIlD DeAthS DUe to AIDS, globAl, 19902011
millions
millions
millions
0
0
0
1990
1990
1990
2011
2011
2011
40
5
3
Source: UNAIDS estimates.
7/29/2019 20121120 UNAIDS Global Report 2012 En
12/11010
UNAIDS
In some other parts o the world, HIV trends (or children and adults) are cause
or concern. Since 2001, the number o people newly inected in the Middle East
and North Arica has increased by more than 35% (rom 27 000 [22 00034 000]
to 37 000 [29 00046 000]). Evidence indicates that the incidence o HIV inection
in Eastern Europe and Central Asia began increasing in the late 2000s afer having
remained relatively stable or several years.
Numr n intd it hIV, 20012011, rin
High estimate
Estimate
Low estimate
ASIA
Numberofpeoplenewlyinfec
tedwithHIV
(thousands)
02001 2011
800
02001 2011
30
Numberofpeoplenewly
infectedw
ithHIV(thousands)
cARIbbeAN
02001 2011
250
Numberofpeoplenewly
infectedwithHIV(thousands)
eASteRN eURope AND ceNtRAl ASIA
02001 2011
150
Numberofpeoplenewly
infectedwithHIV(thousands)
lAtIN AmeRIcA
02001 2011
50
Numberofpeoplenewly
infectedwithHIV(thousands)
mIDDle eASt AND NoRth AFRIcA
02001 2011
5
Numberofpeoplenewly
infectedwithHIV(thousands)
oceANIA
NumberofpeoplenewlyinfectedwithHIV(thousands)
SUb-SAhARAN AFRIcA
0
3 000
2001 2011
Source: UNAIDS estimates.
7/29/2019 20121120 UNAIDS Global Report 2012 En
13/11011
2012 GLOBAL REPORT
During the past decade, many national epidemics have changed dramatically. In
39 countries, the incidence o HIV inection among adults ell by more than 25%
rom 2001 to 2011 (see table). wenty-three o the countries with steep declines in
HIV incidence are in sub-Saharan Arica, where the number o people acquiring
HIV inection in 2011 (1.8 million [1.6 million2.0 million]) was 25% lower than in
2001 (2.4 million [2.2 million2.5 million]). Despite these gains, sub-Saharan Arica
accounted or 71% o the adults and children newly inected in 2011, underscoring
the importance o continuing and strengthening HIV prevention eorts in the
region.
Epidemiological trends are less avourable in several other countries. In at least nine
countries, the number o people newly inected in 2011 was at least 25% higher than in
2001.
cans in t inidn rat hIV intin amn aduts 1549 ars d, 20012011,
std untris
a Countries with incidence rate changes less than 25% up or down.
Source: UNAIDS estimates.
Countries not included in this table have insufficient data and/or analyses to estimate recent trends in incidence among adults and to assess the impact of
HIV prevention programmes for adults. The analysis was either publ ished in peer-reviewed literature or was done through recommended modelling tools for
national HIV/AIDS estimation. Criteria for inclusion of countries with estimation models include that at least four years of HIV surveillance prevalence data were
available for countries with concentrated epidemics and three years for countries with generalized epidemics for each subpopulation used in the estimation,
that HIV surveillance data were available through at least 2009 and that the estimated trend in incidence was not contradicted by other data sources. For some
countries with complex epidemics, including multiple population groups with different risk behaviours as well as major geographical differences, such as Brazil,
China and the Russian Federation, this type of assessment is highly complex and could not be concluded in the 2012 estimation round.
State o the epidemic
Inrasin>25%
Bangladesh
Georgia
Guinea-Bissau
Indonesia
Kazakhstan
Kyrgyzstan
Philippines
Republic of MoldovaSri Lanka
Drasin2649%
Drasin50%
Burundi
Cameroon
Democratic Republic of the Congo
Jamaica
Kenya
Malaysia
Mali
Mexico
Mozambique
Niger
Sierra Leone
South Africa
SwazilandTrinidad and Tobago
Bahamas
Barbados
Belize
Botswana
Burkina Faso
Cambodia
Central African Republic
Djibouti
Dominican Republic
Ethiopia
Gabon
Ghana
Haiti
India
Malawi
Myanmar
Namibia
Nepal
Papua New Guinea
Rwanda
Suriname
Thailand
Togo
ZambiaZimbabwe
Saa
Angola
Belarus
Benin
Congo
France
Gambia
Lesotho
Nigeria
Tajikistan
Uganda
United Republic of TanzaniaUnited States of America
7/29/2019 20121120 UNAIDS Global Report 2012 En
14/11012
UNAIDS
ReDUcTIoNS IN DeAThS fRoM AIDS-RelATeD cAUSeS
Te number o people dying rom AIDS-related causes began to decline in the
mid-2000s because o scaled-up antiretroviral therapy and the steady decline in HIV
incidence since the peak in 1997. In 2011, this decline continued, with evidence that
the drop in the number o people dying rom AIDS-related causes is accelerating inseveral countries.
In 2011, 1.7 million [1.5 million1.9 million] people died rom AIDS-related causes
worldwide. Tis represents a 24% decline in AIDS-related mortality compared with
2005 (when 2.3 million [2.1 million2.6 million] deaths occurred).
Te number o people dying rom AIDS-related causes in sub-Saharan Arica
declined by 32% rom 2005 to 2011, although the region still accounted or 70%
o all the people dying rom AIDS in 2011. Te Caribbean (48%) and Oceania
(41%) experienced signicant declines in AIDS-related deaths between 2005 and
2011. More modest declines occurred during the same period in Latin America
(10%), Asia (4%) and Western and Central Europe and North America (1%). wo
other regions, however, experienced signicant increases in mortality rom AIDS
Eastern Europe and Central Asia (21%) and the Middle East and North Arica
(17%).
A review o country experiences vividly illustrates the changes in AIDS-related
mortality patterns in the past several years (see table). In 14 countries, the annual
number o people dying rom AIDS-related causes declined by at least 50% rom
2005 to 2011. In an additional 74 countries, more modest but still notable declines o
1049% were recorded over the same six-year period.
Te scaling up o antiretroviral therapy in low- and middle-income countries has
transormed national AIDS responses and generated broad-based health gains. Since
1995, antiretroviral therapy has saved 14 million lie-years in low- and middle-
income countries, including 9 million in sub-Saharan Arica. As programmatic
scale-up has continued, health gains have accelerated, with the number o lie-years
saved by antiretroviral therapy in sub-Saharan Arica quadrupling in the last our
years. Experience in the hyper-endemic KwaZulu-Natal Province in South Arica
illustrates the macroeconomic and household livelihood benets o expanded
treatment access, with employment prospects sharply increasing among individuals
receiving antiretroviral therapy.
1.7mIllIoN DIeD
In 2011, 1.7 miin
rdid did rm
AIDS-ratd auss, dn
24% rm t ak in 2005.
7/29/2019 20121120 UNAIDS Global Report 2012 En
15/11013
2012 GLOBAL REPORT
prnta an in t numr din rm AIDS-ratd auss, 20052011a
Dras50%
Botswana
Burundi
Cambodia
Cte dIvoire
Dominican Republic
Ethiopia
Guyana
Kenya
Namibia
Peru
Rwanda
Suriname
Zambia
Zimbabwe
Afghanistan
Algeria
Angola
Armenia
Australia
Azerbaijan
Bangladesh
Belarus
Belize
Brazil
Bulgaria
Cameroon
Canada
Cape VerdeColombia
Costa Rica
Cuba
Ecuador
Egypt
Equatorial Guinea
France
Gabon
Gambia
Georgia
Guatemala
Guinea-Bissau
Indonesia
Iran (Islamic Republic of)
Italy
Kazakhstan
Kyrgyzstan
Lao Peoples DemocraticRepublic
Latvia
Lebanon
Madagascar
Malaysia
Mauritania
Mauritius
Morocco
Mozambique
Myanmar
Nepal
Nicaragua
Niger
Nigeria
Pakistan
Philippines
Poland
Republic of Moldova
Romania
Russian Federation
Senegal
Serbia
Sierra Leone
Singapore
Somalia
Sri Lanka
Sudan
Tajikistan
Togo
UgandaUkraine
United Kingdom
United States of America
Uruguay
Venezuela
Viet Nam
Yemen
N an r dras
7/29/2019 20121120 UNAIDS Global Report 2012 En
16/11014
UNAIDS
Adus and idrn iin wi hIv Adus and idrn nw infd wi hIv
SUb-SAhARAN AFRIcA2011
23.5 iin 1.8 iin[22 100 00024 800 000] [1 600 0002 000 000
200120.9 iin 2.4 iin
[19 300 00022 500 000] [2 200 0002 500 000
mIDDle eASt AND NoRth AFRIcA2011
300 000 37 000[250 000360 000] [29 00046 000
2001210 000 27 000
[170 000270 000] [22 00034 000
SoUth AND SoUth-eASt ASIA2011
4.0 iin 280 000
[3 100 0004 600 000] [170 000370 000
20013.7 iin 370 000
[3 200 0005 100 000] [250 000450 000
eASt ASIA2011
830 000 89 000
[590 0001 200 000] [44 000170 000
2001390 000 75 000
[280 000530 000] [55 000100 000
oceANIA2011
53 000 2 900
[47 00060 000] [2 2003 800
200138 000 3 700
[32 00046 000] [3 1004 300
lAtIN AmeRIcA2011
1.4 iin 83 000
[1 100 0001 700 000] [51 000140 000
2001 1.2 iin 93 000[970 0001 500 000] [67 000120 000
cARIbbeAN2011
230 000 13 000
[200 000250 000] [960016 000
2001240 000 22 000
[200 000270 000] [20 00025 000
eASteRN eURope AND ceNtRAl ASIA2011
1.4 iin 140 000
[1 100 0001800 000] [91 000210 000
2001970 000 130 000
[760 0001 200 000] [99 000170 000
WeSteRN AND ceNtRAl eURope2011
900 000 30 000
[830 0001 00 000] [21 00040 000
2001640 000 29 000
[590 000710 000] [26 00034 000
NoRth AmeRIcA2011
1.4 iin 51 000
[1 100 0002 000 000] [19 000120 000
20011.1 iin 50 000
[850 0001 300 000] [35 00071 000
globAl 201134.0 iin 2.5 iin
[31 400 00035 900 000] [2 200 0002 800 000
200129.4 iin 3.2 iin
[27 200 00032 100 000] [2 900 0003 400 000
Source: UNAIDS estimates.
Rina hIV and AIDS statistis, 2001, 2005 and 2011
7/29/2019 20121120 UNAIDS Global Report 2012 En
17/11015
2012 GLOBAL REPORT
(1549 ars) ran, % pran, un (1524 ars), % AIDS-rad das an adus and idrn,2005 and 2011Women Men
4.9 3.1 1.32011
1.2 iin[4.65.1] [2.63.9] [1.11.7] [1 100 0001 300 000]
5.9 5.1 2.02005
1.8 iin
[5.46.2] [4.26.7] [1.62.7] [1 600 0001 900 000]
0.2
7/29/2019 20121120 UNAIDS Global Report 2012 En
18/11016
UNAIDS
Getting to zero new HIV inections will require substantial reductions each year
in sexual HIV transmission, which accounts or the overwhelming majority o the
people who are newly inected. Although there is reason or optimism, including
avourable trends in sexual behaviour in many countries and the additive impact
o new biomedical prevention strategies, the current pace o progress is insucient
to reach the global goal o halving sexual transmission by 2015, underscoring the
urgent need or intensied action.
Getting to zero new inections will require eective combination prevention: using
behavioural, biomedical and structural strategies in combination, both intensivelyin specic populations in concentrated epidemics and across the whole population
in generalized epidemics (1,2).1 Critical programmatic elements o combination
prevention o the sexual transmission o HIV include behaviour change, condom
provision, male circumcision, ocused programmes or sex workers and men who
have sex with men and access to antiretroviral therapy.
behAVIoUR chANge IS helpINg To pReVeNT SexUAl
TRANSMISSIoN IN geNeRAlIzeD epIDeMIcS
Behaviour change programmes seek to promote saer individual behaviour as well
as changes in social norms that generate healthier patterns o sexual behaviour.
Behaviour change is complex; it involves knowledge, motivations and choices,
which are inuenced by sociocultural norms, as well as risk assessment in relation
to immediate benets and uture consequences. It involves both rational decision-
making and impulsive and automatic behaviour (3). HIV behaviour change
programmes have largely been measured against the outcomes o reduction in the
number o young people initiating sexual intercourse early and the number o sexual
partners and increase in the correct and consistent use o condoms among peoplewho are sexually active.
1 sexUAl trAnsMIssIon
1 Tis section reports on available inormation regarding sexual behaviour in the general population, coverage o male circumcision and HIV among sex workers and men who have sex with men. Unlessotherwise indicated, data are rom the 2012 country progress reports (www.unaids.org/cpr). Data on key populations at higher risk rom country progress reports typically derive rom surveys in capital c itiesand are not representative o the entire country. In particular, surveys in capital cities are likely to overestimate national HIV prevalence and service coverage.
7/29/2019 20121120 UNAIDS Global Report 2012 En
19/11017
2012 GLOBAL REPORT
Fig. 1.1
Sua risks: ans in t rntas mn and mn 1524 ars d avin sr a 15 ars; mn and mn 1549 ars d avin muti artnrs; and ts
it muti artnrs usd a ndm at ast s, in std untris it adut hIVrvan ratr tan 1%, r std ars 20002011a
a Sex before age 15 years in Ethiopia is for the years 2000 and 2011.
Sources:nationally representative household surveys.
To measure progress towards these aims, countries monitor the percentage of young men and women who report having sex before age 15 years, the
percentage of men and women who report having more than one partner during a 12-month period and the percentage of men and women reporting more
than one sexual partner in the previous year who also report using a condom during their last episode of sexual intercourse.
Increasing risk behaviour,statistically significant
Increasing risk behaviour, notstatistically significant
Decreasing risk behaviour,statistically significant
Decreasing risk behaviour, notstatistically significant
Not available or based on fewerthan 50 respondents
Sexual transmission
Sx fr a 15 ars an15- 24-ar-ds
mui arnrs in as 12ns an 15- 49-ar-ds
cnd us a as i-risk sxan 15- 49-ar-ds
yars farisn
Women Men Women Men Women Men
bnin 2001 2006
burkina Fas 2003 2011
carun 2004 2011cn 2005 2009
c d'Iir 2005 2011
eiiaa 2005 2011
gana 2003 2008
guana 2005 2009
haii 2000 2005
Kna 2003 2008
ls 2004 2009
maawi 2000 2010
mai 2001 2006
mzaiqu 2003 2009
Naiia 2000 2006
Niria 2003 2008
Rwanda 2000 2010
Su Afria 2005 2008
Uanda 2000 2011
Unid Ruif tanzania
2004 2010
Zaia 2001 2007
Ziaw 2005 2010
7/29/2019 20121120 UNAIDS Global Report 2012 En
20/11018
UNAIDS
2 Angola, Botswana, Burkina Faso, Burundi, Cameroon, Central Arican Republic, Chad, Congo, Democratic Republic o the Congo, Gabon, Ghana, Guinea-Bissau, Haiti, Kenya, Lesotho, Nigeria and ogo.
Fig. 1.1 indicates that sexual behaviour among men and women has changed
avourably in numerous countries with generalized epidemics. Favourable changes
in risky sexual behaviour are evident in many countries, including Kenya, Malawi,
Mozambique, Namibia, Nigeria and Zambia. In other countries such as Cte
dIvoire, Guyana and Rwanda increases in sexual risk behaviour are ound,
highlighting the need to intensiy support or behaviour change eorts.
Age-appropriate sexuality education may increase knowledge and contribute
to more responsible sexual behaviour. However, there are signicant gaps in
even basic knowledge about HIV and its transmission. In 26 o 31 countries
with generalized epidemic in which nationally representative surveys were
carried out recently, less than 50% o young women have comprehensive and
correct knowledge about HIV. Notably, young women are lacking in knowledge
concerning the eectiveness o condoms in preventing HIV transmission. In 21 o
25 countries with nationally representative surveys, young men had less than 50%
comprehensive and correct knowledge about HIV.
Although population-level behaviour change has been shown to reduce the
prevalence o HIV inection in several countries with generalized epidemics
(46), linking behaviour change programming to specic HIV outcomes
remains challenging. Te consistent association between behaviour change and
reduced incidence provides plausible support or the impact o behaviour change
programming in general, but more specic evidence showing which programmatic
elements have which eects is urgently needed to help guide wise investment (see
the section on the state o the epidemic or changes in the number o people newly
inected with HIV). Disentangling the attribution o eects between specic HIV
programme elements and more general changes in the enabling environment, such
as stigma reduction and universal education, is also dicult (see Section 8).
Tese challenges make it dicult to draw clear conclusions about the scale o
unding needed or behaviour change programming. Among the 26 countries with
generalized epidemics that submitted expenditure data or the most recent year, an
average o 5% o HIV expenditure was allocated to behaviour change programming
(including condom promotion), representing 36% o overall prevention spending.
Some evidence indicates absolute increases in spending: among 17 countries with
comparable data over multiple years,2 total expenditure on behaviour change
programming (including condom promotion) rose rom US$ 148 million in
2008 to US$ 190 million in 2010. Tese gures include spending on HIV-related
inormation, education and communication about HIV; community mobilization;
risk reduction or vulnerable populations; social marketing o condoms; preventing
sexually transmitted inections; behaviour change communication; and prevention
activities among youth, among others (Fig. 1.2).
7/29/2019 20121120 UNAIDS Global Report 2012 En
21/11019
2012 GLOBAL REPORT
Fig. 1.2
enditur n anin aviur and rmtin ndm us in 17 untris itnraid idmis and avaia data, 20082010
200
160
120
80
40
0
exnditurinmillionsof
USdollars
2008
148
2009
161
2010
190
Source: 2012 country progress reports (www.unaids.org/cpr).
DISTRIbUTINg AND pRoMoTINg coNDoMS
Condom use is a critical element o combination prevention and one o the most
ecient technologies available to reduce the sexual transmission o HIV. Although
levels o reported condom use appear to be increasing in several countries with a
high prevalence o HIV inection, recent data rom nationally representative surveys
indicate declines in condom use in Benin, Burkina Faso, Cte dIvoire and Uganda
(Fig. 1.1). In addition, knowledge about condoms remains low in several o the
high-prevalence countries, especially among young women.
Te United Nations Population Fund (UNFPA) estimates that only nine
donor-provided male condoms were available or every man aged 1549 years in
sub-Saharan Arica in 2011 and one emale condom or every 10 women aged 1549
years in the region. Less is known about the procurement o condoms by low- and
middle-income countries directly. One estimate (7) suggests that low- and middle-
income countries directly procured more than 2 billion condoms in 2010 compared
with an estimated 13 billion condoms required or HIV prevention in 2015 (8).
Sexual transmission
7/29/2019 20121120 UNAIDS Global Report 2012 En
22/11020
UNAIDS
Increasing condom use requires both adequate supply and adequate demand. A
recent study in Kenya estimated that, although condom use was low in the study
population, so was the unmet need or condoms, highlighting the importance o
building demand or condoms in the context o HIV prevention (9). Te demand or
condoms to protect against HIV inection may also be aected by other prevention
programmes, such as perceptions that risks are lower because o interventionssuch as male circumcision or post-exposure prophylaxis or that partners receiving
antiretroviral therapy will be less inectious, and similarly, the consequences o
HIV inection may be seen as less devastating in the era o eective therapy thus
decreasing the need or protection. Tese potential risk compensation eects are
being closely scrutinized, but the dynamics are complex to track.
lIMITeD pRogReSS IN bRINgINg VolUNTARy MeDIcAl MAle
cIRcUMcISIoN To ScAle
Male circumcision reduces the likelihood that men will acquire HIV rom a emale
partner. Since 2007, WHO and UNAIDS have recommended voluntary medical
male circumcision in countries with high rates o HIV inection and low rates o
male circumcision. Rapidly scaling up voluntary medical male circumcision has the
potential to prevent estimated 1 in 5 o the people who would have acquired HIV
inection rom doing so in eastern and southern Arica through 2025 (10). Most
countries in which voluntary medical male circumcision is recommended have
endorsed the intervention, adopted roll-out policies and begun training health care
workers in administering circumcision procedures.
>20%
Ethiopia
Kenya
Swaziland
Table 1.1
prnta t 2015 natina tarts r ma irumisins mt 2011
7/29/2019 20121120 UNAIDS Global Report 2012 En
23/11021
2012 GLOBAL REPORT
Countries that have given priority to male circumcision have established national
targets or the number o voluntary medical male circumcisions to be perormed by
2015. Rolling out medical male circumcision in Kenya is ocused on Nyanza Province,
where 54% o the targeted 230 000 male circumcisions have been perormed as o
December 2011. Ethiopia and Swaziland achieved more than 20% o their national
target or voluntary medical male circumcision. In other priority countries, progress
has been much slower (able 1.1). In six countries (Malawi, Mozambique, Namibia,
Rwanda, Uganda and Zimbabwe), less than 5% o the target number o men had been
circumcised by the end o 2011 (11). Only two o the priority countries (Ethiopia and
Swaziland) have integrated male circumcision into inant care programmes.
Te unit cost o voluntary medical male circumcision is relatively low, and unlike
most other prevention or treatment eorts, requires only one-time rather than
lielong expenditure. Nevertheless, countries have allocated relatively ew resources
towards scaling up this intervention, with less than 2% o total HIV expenditure
allocated to voluntary medical male circumcision in 6 o the 14 priority countries
with data available (Botswana, Kenya, Lesotho, Namibia, Rwanda and Swaziland).
Some countries, such as Botswana, Kenya, Namibia and Swaziland, have increased
expenditure or rolling out circumcision more recently. Given the lielong risk
reduction that male circumcision coners, it is clear that, the earlier programmes
invest in ensuring high levels o coverage, the better.
pReVeNTINg hIV INfecTIoN IN Sex woRK
Te number o countries reporting data on epidemiological trends and service
coverage pertaining to sex workers signicantly increased rom 2006 to 2012, reecting
greater ocial recognition o the HIV-related needs o this population. Among
generalized epidemic countries, country-reported HIV prevalence is consistently
higher among sex workers in the capital city than among the general population with
a median o 23% (Fig. 1.4). Median country-reported HIV prevalence among sex
workers in the capital cities has remained stable between 2006 and 2011. Similarly, a
recent review o available data rom 50 countries, which estimated the global HIV
prevalence among emale sex workers at 12%, ound that emale sex workers were
13.5 times more likely to be living with HIV than are other women (12).
Nearly three quarters o reporting countries (73%) indicated they have implemented
risk-reduction programmes or sex workers. Among 58 countries reporting data
rom surveys in capital cities, the median coverage o HIV prevention services
or sex workers is 56% (able 1.2), only marginally higher than in 2010, with 11
countries reportedly reaching at least 80% o sex workers. Although country-
reported data remain limited and consistent comparisons across countries are
dicult, countries that lack legal protections or sex workers appear to have lower
median prevention coverage. According to data provided by 85 countries, 85% o sex
workers in capital cities report having used a condom the last time they had sex.
Sexual transmission
13.5fma s rkrs ar
13.5 tims mr ik t ivin
it hIV tan ar tr mn.
7/29/2019 20121120 UNAIDS Global Report 2012 En
24/11022
UNAIDS
Programmes targeting sex workers are common but are ar less consistently available
or the clients o sex workers. Programmes that eectively target and engage the
clients o sex workers are a critical omission, as this is a large population in many
countries, and reducing the demand or unprotected paid sex is an important
complement to programmes that target sex workers themselves.
Te vast majority o countries (86%) address sex work in their multisectoral AIDS
strategies. Although most country reports on sex workers pertain to emales, a
growing number o countries (10% in 2012) also provided inormation on male sex
workers.
Funding or HIV prevention programmes or sex workers has increased signicantly
in recent years. Among 30 countries that reported spending or sex worker
programming (with data available or at least one year in 20062007, 20082009
or 20102011), total spending rose 3.7-old during 20062011. Funding patterns
raise questions regarding the uture sustainability o prevention programmes or
sex workers. International unding has generated almost all the increased unding
and accounted or 91% o total spending on HIV programmes or sex workers in
20102011.
Fig. 1.3
hIV sndin n rvntin rramms r s rkrs and tir ints30 low- and middle-income countries with available data, latest year available
35
20
25
30
15
5
10
0
International
Domestic public
2008 or 2009
M
illionsofUSdollars
2006 or 2007 2010 or 2011
Source: 2012 country progress reports (www.unaids.org/cpr).
7/29/2019 20121120 UNAIDS Global Report 2012 En
25/11023
2012 GLOBAL REPORT
Sexual transmission
Fig. 1.4
prvan hIV intin amn s rkrs vrsus t nra uatin in untris itavaia data, 2012
Prevalence among sex workers (%) reported by the country (2012)
Afghanistan
Bolivia
Papua New Guinea
Czech Republic
Indonesia
Senegal
Philippines
Madagascar
Tunisia
Tajikistan
Cape Verde
Bulgaria
Suriname
Lebanon
Guyana
Romania
Chile
Burundi
Georgia
Honduras
Guinea
Armenia
Viet Nam
Estonia
Mexico
Dominican Republic
Sierra Leone
Jamaica
Guinea-Bissau
Chad
Nigeria
Uganda
Swaziland
0 10% 20% 30% 40% 50% 60% 70% 80%
Prevalence among people 1549 years old (2011)
Sources: prevalence for the general population: UNAIDS estimates for 2011; prevalence for sex workers: 2012 country progress reports (www.unaids.org/cpr).
Sex workers are classified as having received prevention services if they respond yes to whether they know where to get HIV testing and have been given
condoms in the past 12 months.
These data were reported in 2012, but countries may differ in methods. Surveys are usually conducted in capital cities and may not be nationally representative.
Data is only shown for countries which have reported a sample size greater than 100.
Belarus
Malaysia
Panama
7/29/2019 20121120 UNAIDS Global Report 2012 En
26/11024
UNAIDS
Source: 2010 and 2012 country progress reports (www.unaids.org/cpr).
These data were reported in 2012, but countries may differ in methods. Surveys are usually conducted in capital cities and may not be nationally representative.
Table 1.2
Rrtd vra hIV rvntin rramms amn s rkrs in std untris,2012 untr rrts
75100%
Angola
Belarus
Cape Verde
China
Cuba
Djibouti
Estonia
Guinea
Haiti
JamaicaKazakhstan
Mauritius
Myanmar
Senegal
Tajikistan
Togo
Nn-rrin unris
5074%
Bulgaria
Burkina Faso
Chad
Cte dIvoire
France
Ghana
Lao Peoples Democratic Republic
Mexico
MongoliaParaguay
Philippines
Serbia
Thailand
Ukraine
Uzbekistan
7/29/2019 20121120 UNAIDS Global Report 2012 En
27/11025
2012 GLOBAL REPORT
Sexual transmission
ReSpoNDINg To The globAl hIV epIDeMIc AMoNg MeN
who hAVe Sex wITh MeN
Te HIV prevalence among men who have sex with men in capital cities is consistently
higher than that in the general population (Fig. 1.6) (13). Te prevalence o HIV
inection among men who have sex with men in surveys in capital cities is on average13 times higher than that in the countrys general population. Studies in East Asia
suggest rising trends in HIV prevalence among men who have sex with men, and some
evidence indicates that the global prevalence o HIV inection among men who have
sex with men may have increased rom 2010 to 2012, although data are limited and the
use o diverse study methods creates diculty in comparing results across settings and
time (13,14).
Fig. 1.5
hIV sndin n rvntin rramms r mn av s it mn21 low- and middle-income countries with available data, latest year available
16
8
10
12
14
6
2
4
0
International
Domestic public
2008 or 2009
MillionsofUSdollars
2006 or 2007 2010 or 2011
Source: 2012 country progress reports (www.unaids.org/cpr).
7/29/2019 20121120 UNAIDS Global Report 2012 En
28/11026
UNAIDS
Fig. 1.6
prvan hIV intin amn mn av s it mn vrsus t nra uatinin untris it avaia data, mst rnt ar
Bangladesh
Bulgaria
Czech Republic
China
Egypt
Fiji
Japan
Germany
Mongolia
Hungary
Philippines
Lebanon
Republic of Korea
Lithuania
Tunisia
Serbia
Algeria
Slovenia
Azerbaijan
Armenia
Cuba
Georgia
Greece
Kazakhstan
Mexico
Morocco
Netherlands
Nicaragua
Sweden
Yemen
Bolivia
Brazil
Costa Rica
Indonesia
Ireland
Madagascar
Nepal
Paraguay
Tajikistan
0 5% 10% 15% 20%
Argentina
Belarus
Ecuador
7/29/2019 20121120 UNAIDS Global Report 2012 En
29/11027
2012 GLOBAL REPORT
Sexual transmission
31%
37%
35%
26%
Cameroon
Nigeria
Switzerland
Chile
Republic of Moldova
France
Viet Nam
Myanmar
Portugal
Ukraine
Malaysia
Cambodia
Uruguay
Senegal
Mauritius
Spain
Peru
El Salvador
Honduras
Latvia
Dominican Republic
Panama
Guatemala
emocratic Republic of the Congo
Sierra Leone
Central African Republic
Swaziland
0 5% 10% 15% 20%
Kenya
22%
23%
Thailand
Sources: prevalence in the general population: UNAIDS estimates for 2011; prevalence among men who have sex with men: 2012 country progress reports
(www.unaids.org/cpr): the surveys are from multiple years between 2005 and 2011.
These data were reported in 2012, but countries may differ in methods. Surveys are usually conducted in capital cities and may not be nationally representative.
Data is only shown for countries which have reported a sample size greater than 100.
Prevalence among men who have sex with men (%) reportedby the country (2012)
Total prevalence among people 1549 years old (2011)
Angola
Haiti
Togo
Burkina Faso
Uzbekistan
7/29/2019 20121120 UNAIDS Global Report 2012 En
30/11028
UNAIDS
Prevention coverage remains inadequate or men who have sex with men. Globally,
the median prevention coverage measured in surveys in capital cities is 55%, with
a majority o countries reportedly achieving at least 40% coverage or men who
have sex with men (able 1.3). Te median proportion o men who have sex with
men who received an HIV test in the last 12 months is 38%, with ewer than 1 in 3
men being tested in the past 12 months in South and South-East Asia and Western
and Central Europe, where men who have sex with men play a substantial role in
national epidemics (able 1.4).
One o the reasons or the persistent epidemic among men who have sex with men
is that levels o consistent condom use are insucient. Although a majority o
surveyed men who have sex with men said that they used a condom during their
last episode o sexual intercourse in 69 o 96 countries reporting, in only 13 o these
countries did more than 75% do so (able 1.5). More inormation is needed on the
extent o non-condom use among regular partners o known concordant HIV status,
but rates o consistent condom use in this population clearly need to increase to curb
the epidemic.
More countries are acknowledging the existence o men who have sex with men as a
key population in relation to the epidemic, reected both in the inclusion o men who
have sex with men in national strategies in 146 countries and in increased reporting
o prevalence data. Te number o countries reporting data on HIV prevalence
among men who have sex with men rose rom 67 in 2010 to 104 in 2012, with an
additional 62 countries acknowledging the relevance o this indicator but reporting
that data were unavailable. Eleven countries reported that this indicator would be
irrelevant. Reporting on men who have sex with men has notably increased in sub-
Saharan Arica: rom 11 countries in 2010 to 22 countries in 2012. Te countries that
include men who have sex with men in national AIDS strategies reported data on this
population, whereas only 4 o the 15 countries that do not include this population in
their national strategies reported data on relevant indicators in 2012.
Funding or HIV programmes or men who have sex with men increased between
2006 and 2011. Among 21 countries reporting HIV spending data or men who have
sex with men (with data available or at least one year in each o 20062007, 20082009
and 20102011), total spending increased 3.2-old.
Although countries are increasingly recognizing the need to address HIV amongmen who have sex with men, recent increases in resources or HIV programmes or
men who have sex with men have primarily resulted rom the eorts o international
donors. In 20102011, international unding accounted or 92% o all spending on
HIV programmes or men who have sex with men. Among 58 countries reporting
expenditure or men who have sex with men, 45 relied primarily on external sources
or such programming, including 19 o 21 upper-middle-income countries.
38%teSteD
T mdian rrtin
mn av s it mn
rivin an hIV tst in t
ast 12 mnts is 38%.
7/29/2019 20121120 UNAIDS Global Report 2012 En
31/11029
2012 GLOBAL REPORT
Sexual transmission
Table 1.3
Rrtd vs vra rvntin rramms amn mn av s it mn, mstrnt ar
7/29/2019 20121120 UNAIDS Global Report 2012 En
32/11030
UNAIDS
Afghanistan
Algeria
Andorra
Antigua and Barbuda
Austria
Bahrain
Barbados
Benin
Bhutan
Botswana
Brunei Darussalam
Cape Verde
Chad
Comoros
Congo
Croatia
CyprusDemocratic Peoples Republic of Korea
Democratic Republic of the Congo
Djibouti
Equatorial Guinea
Eritrea
Ethiopia
Fiji
Gabon
Ghana
Grenada
Guinea
Guinea-Bissau
Hungary
Iceland
India
Iran (Islamic Republic of)
Iraq
Israel
Jordan
Kiribati
KuwaitLao Peoples Democratic Republic
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Malawi
Maldives
Malta
Mauritania
Micronesia (Federated States of)
Monaco
Mozambique
Namibia
Nauru
New Zealand
Niger
Oman
Pakistan
Palau
QatarRussian Federation
Rwanda
Saint Lucia
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Sierra Leone
Slovakia
Solomon Islands
Somalia
South Sudan
Syrian Arab Republic
Tonga
Trinidad and Tobago
Turkey
Turkmenistan
Tuvalu
Uganda
United Arab Emirates
United Republic of TanzaniaVanuatu
Venezuela (Bolivarian Republic of)
Zambia
Zimbabwe
Table 1.4
Rrtd vs vra hIV tstin amn mn av s it mn, mst rnt ar
7/29/2019 20121120 UNAIDS Global Report 2012 En
33/11031
2012 GLOBAL REPORT
Sexual transmission
Table 1.5
Rrtd vs ndm us amn mn av s it mn, mst rnt ar
7/29/2019 20121120 UNAIDS Global Report 2012 En
34/11032
UNAIDS
Full and eective combination o available prevention strategies has conclusively
demonstrated the capacity to rapidly reduce the number o people newly inected
with HIV. o make the best use o these combination prevention options, countries
need to closely ocus on the driving orces and key populations at higher risk o
their national epidemics. Behaviour change, biomedical interventions and structural
approaches to reduce the underlying vulnerability to HIV inection should be
implemented in concert or maximum impact.
Newly emerging evidence rom Kenya and Malawi indicates that even quite small
cash transers can markedly aect the dynamics o sexual transmission o HIV. In
Kenya, young people who received a cash transer were less likely to have ever had
sex and, when sexually active, less likely to have had more than two sexual partners
in the past 12 months (15). In Malawi, a cash transer intervention led to signicant
declines in early marriage, teenage pregnancy and sel-reported sexual activity(16).
Te promise o antiretroviral therapy in preventing HIV transmission, with
well-established evidence in relation to mother-to-child transmission, has come
into sharp ocus during the past two years. In 2011, researchers reported that
antiretroviral therapy reduces the odds o sexual transmission within serodiscordant
heterosexual partners (17), and in 2012 WHO issued guidelines on serodiscordant
couples to recommend that the partner living with HIV be oered antiretroviral
therapy regardless o his or her CD4 count (18). In addition to the reduced
transmission o HIV resulting rom ully eective viral suppression among people
living with HIV, trials have also indicated that antiretroviral medicines can reduce
the likelihood that an uninected person will acquire HIV. Te potential public
health impact o this strategy in reducing HIV incidence greatly depends on the
extent to which potential HIV-uninected users o antiretroviral medicines or
prophylactic purposes are able to adhere to daily dosing regimens.
In priority countries in sub-Saharan Arica, additional steps are needed to accelerate
the scaling up o voluntary medical male circumcision. Although some countries
have reported strong demand or voluntary medical male circumcision where
such services have been oered, generating robust demand or the service remains
a challenge in other priority countries. Investing in community engagement and
mobilization represents an urgent priority to accelerate scale-up. Intensive eorts
are underway to evaluate potentially promising non-surgical devices or male
circumcision. By avoiding the need or scalpels or sutures in circumcision, it is
hoped that scale-up can be expedited through substituting trained nurses or
surgeons, thus alleviating health worker shortages and reducing mens resistance
MoVINg foRwARD TowARDS 2015: ReDUcINg SexUAl
TRANSMISSIoN by 50%
7/29/2019 20121120 UNAIDS Global Report 2012 En
35/11033
2012 GLOBAL REPORT
to undergoing the procedure. In 2012, eld trials were underway in Rwanda and
Zimbabwe or PrePex (a device that enables non-surgical and sae adult male
circumcision) and in Kenya and Zambia or the Shang Ring (a circumcision tool
that helps health care providers with limited training to perorm circumcision). A
new device or inants (AccuCirc) is also being evaluated in Botswana. Whether
surgical or non-surgical, voluntary medical male circumcision is a procedure that
has important cultural resonance, underscoring the need or a meaningul cultural
discussion on the signicance and benets o circumcision.
Although encouraging progress has been made in stabilizing HIV prevalence and
promoting condom use among workers in sex work, substantially greater gains will
be needed to halve the sexual transmission o HIV among sex workers by 2015.
Accurate estimates o the size and distribution o sex worker populations will assist
countries in adhering to the know your epidemic, know your response approach
to prevention planning. Programmatic experience has also shown that review and,
where necessary, reorm, o legal and policy rameworks to reduce stigma and
discrimination towards sex workers can promote the increased use o prevention
services.
Services to reduce the sexual transmission o HIV among transgender populations
are also critical. Te severe marginalization experienced by many transgender
people, limited options or employment, persistent stigma and discrimination
and, in many cases, targeted violence, are all actors that increase the vulnerability
to HIV inection or this population (see Section 7 or additional inormation on
transgender populations).
Reaching a higher proportion o men who have sex with men with eective
programmatic eorts is critical i the world is to halve sexual transmission by 2015.
Tis is one o many areas where the lack o domestic unding allocated towards
sound programming not only jeopardizes the sustainability o these programmes
but also suggests that a lack o national ownership is hampering the success o
these eorts. HIV monitoring among men who have sex with men should be
strengthened, and punitive legal rameworks should be revised to bring AIDS
responses in accordance with human rights norms. In addition to eorts ocused on
HIV-related behaviour, access to antiretroviral therapy or men who have sex with
men who are living with HIV and the potential use o pre-exposure prophylaxis
should be combined together in a coordinated and accelerated eort to reduce the
sexual transmission o HIV. Research to develop rectal microbicides should also
continue as a potentially important measure or this population.
Sexual transmission
7/29/2019 20121120 UNAIDS Global Report 2012 En
36/11034
UNAIDS
Te global goal o reducing the number o people who use drugs who acquire HIV
inection by 50% by 2015 recognizes both the epidemics extraordinary toll on this
population and the act that drug-related transmission is driving the expansion
o the epidemic in many countries. Several countries that have implemented
evidence-inormed programmes or people who use drugs have dramatically
reduced the number o these people who acquire HIV inection, with some countries
approaching the elimination o drug-related transmission. However, globally we are
ar rom halving the number o people who use drugs who are newly inected with
HIV by 2015.
people who INJecT DRUgS ARe exTRAoRDINARIly
bURDeNeD
People who inject drugs are among the population groups most severely aected
by HIV inection. In virtually all countries reporting data in 2012, the prevalence
o HIV inection is higher among people who inject drugs than among the general
population (Fig. 2.1). In 49 countries with available data, the prevalence o HIV
inection is at least 22 times higher among people who inject drugs than or thepopulation as a whole, with prevalence at least 50-old higher in 11 countries.
A 2007 study(1) estimated that about 16 million people inject drugs globally,
including many younger than 25 years and 3 million o whom are living with HIV.
In addition to imposing extraordinary burdens on people who use drugs,
drug-related transmission also undermines global eorts to lay the oundation or
the eventual end o AIDS. In Eastern Europe and Central Asia, one o two regions
where the number o people newly inected is rising, national epidemics are
typically driven by drug userelated transmission and by urther transmission to
the sexual partners o people who use drugs.
Low- and middle-income countries, however, have had limited progress in slowing
the spread o HIV among people who inject drugs. Nevertheless, transmission
can be reduced substantially. Such countries as Australia and the United Kingdom
that have implemented evidence-inormed HIV prevention strategies have sharply
reduced the number o people who inject drugs who acquire HIV inection, with
some approaching the elimination o drug-related transmission.
2 PeoPle wHo Inject drUgs
22p injt drus
av 22 tims t rat
hIV intin as t nra
uatin in 49 untris
it avaia data.
7/29/2019 20121120 UNAIDS Global Report 2012 En
37/110
7/29/2019 20121120 UNAIDS Global Report 2012 En
38/11036
UNAIDS
eVIDeNce-INfoRMeD pRogRAMMeS ARe beINg
INADeqUATely ScAleD Up
According to country reports, nearly 80% o people who inject drugs reached in
surveys in 49 capital cities have access to sae injecting equipment, with similar
access reported or men and women. However, evidence rom recently published
studies (2,3) suggests that accessibility to needle and syringe programmes is low
in most countries in which drug use among women is highly stigmatized and that
access to any HIV services among women drug users remains very low compared
with men drug users. In addition, country reports indicate that the scale o such
programmes is inadequate, with most countries indicating that programmes
annually provide ewer than 100 needles per person who injects drugs (able 2.1).1
A separate 2010 study(4) estimated that, globally, two needle-syringes (range 14)
were distributed monthly per person who injects drugs per month, and another
study(5) estimates that people who inject drugs only use sterile injecting equipment
or 5% o injections globally.
Emerging evidence indicates that women who inject drugs may experience risks
that are greater than or men who inject drugs (6). In particular, women who inject
drugs are more vulnerable to violence rom intimate partners, police and sex-trade
clients (7). Combined with homelessness (8) and comorbid mental disorders (9),
these vulnerabilities may act synergistically to increase the risk o exposure to HIV.
Clear evidence indicates that women who inject drugs and are living with HIV
who become pregnant have a substantially lower likelihood o accessing services to
prevent children rom acquiring HIV inection than do other women living with
HIV.
Countries also lag in scaling up other essential prevention measures or people who
inject drugs (ables 2.2 and 2.3). Reported condom use, or example, is lower among
people who inject drugs reached in surveys in capital cities than or sex workers
or men who have sex with men. Among 56 countries reporting data, the median
condom use or people who inject drugs is 40% (3048%), with only 3 countries
reporting condom use above 75%.
HIV testing services are also ailing to reach many people who inject drugs. Among
57 countries reporting, a median o 39% (2260%) o people who inject drugs
reached in surveys in capital cities reported having received an HIV test in the
previous 12 months, with 8 countries reporting testing rates o at least 75%.
1 racking the average number o needles distributed per person who injects drugs is dicult, since it requires reliably estimating the size o national populations using drugs.
7/29/2019 20121120 UNAIDS Global Report 2012 En
39/11037
2012 GLOBAL REPORT
Table 2.1
Numr srins distriutd tru nd and srin rramms r rsn injts drus, mst rnt ar avaia
Oman and Slovenia reported data on the number of syringes distributed but did not have available data on the estimated number of people who inject drugs.
Source: 2012 country progress reports (www.unaids.org/cpr).
These data were reported in 2012, but countries may di ffer in methods. Surveys are usually conducted in capital cities and may not be nationally representative.
lw vra 200
Cambodia
China
Estonia
Hungary
Kazakhstan
Kyrgyzstan
LuxembourgMalaysia
Myanmar
Uzbekistan
Viet Nam
Algeria
Andorra
Argentina
Austria
Bahamas
Bahrain
Bhutan
Bermuda
Bolivia (Plurinational
State of)
Brazill
Brunei Darussalam
Canada
Chile
Colombia
Costa Rica
Cte dIvoire
Croatia
Denmark
Djibouti
Dominican Republic
Ecuador
Egypt
El Salvador
Fiji
France
Gabon
Germany
Ghana
Guatemala
Honduras
Iceland
India
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kenya
Kiribati
Kuwait
Lao Peoples Democratic
Republic
Lebanon
Libya
Malawi
Maldives
Micronesia (Federated
States of)
Monaco
Mongolia
Montenegro
Netherlands
Nicaragua
Nigeria
Oman
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Portugal
Qatar
Republic of Korea
Russian Federation
Samoa
San Marino
Saudi Arabia
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
South Africa
Spain
Sudan
Suriname
Swaziland
Syrian Arab Republic
Taiwan, China
Timor-Leste
Togo
Tonga
Turkey
Uganda
Uruguay
United Arab Emirates
United Kingdom
United Republic ofTanzania
United States of America
Vanuatu
Venezuela (Bolivarian
Republic of)
Yemen
Zambia
mdiu vra100200
Nn-rrin unris wi w inj drusa
Australia
Bangladesh
Czech Republic
Finland
MadagascarMalta
New Zealand
Norway
Sweden
a Mathers BM et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
Lancet, 2010, 375:10141028.
People who inject drugs
7/29/2019 20121120 UNAIDS Global Report 2012 En
40/11038
UNAIDS
Table 2.2
Rrtd hIV tstin vra amn injt drus, mst rnt ar avaia
75100%
Canada
Indonesia
Luxembourg
Malaysia
New ZealandRomania
Seychelles
5074%
Belarus
Finland
Kazakhstan
Kenya
Kyrgyzstan
Lithuania
Netherlands
Paraguay
Senegal
SwitzerlandThe former Yugoslav Republic
of Macedonia
2549%
Albania
Australia
Bhutan
Bosnia and Herzegovina
Bulgaria
Cambodia
China
Czech Republic
Estonia
Germany
Mauritius
Mexico
Myanmar
Serbia
South Sudan
Sweden
Syrian Arab Republic
Tajikistan
Thailand
Ukraine
United States of AmericaUzbekistan
Viet Nam
7/29/2019 20121120 UNAIDS Global Report 2012 En
41/11039
2012 GLOBAL REPORT
75100%
5074%
2549%
7/29/2019 20121120 UNAIDS Global Report 2012 En
42/110
7/29/2019 20121120 UNAIDS Global Report 2012 En
43/11041
2012 GLOBAL REPORT
hAlVINg The NUMbeR of people who INJecT DRUgS
AcqUIRINg hIV INfecTIoN: TowARDS 2015
Available evidence indicates that the world is ar rom being on track to achieve
the global target or people who inject drugs. Substantially stronger commitmentis urgently needed to bring evidence-inormed responses to scale. As many
countries ail to report data on HIV and people who inject drugs, immediate steps
are needed to improve the reporting o sex-aggregated epidemiological and HIV
service coverage data or this population, with the aim o ensuring reliable national
estimates o the total number o people who inject drugs. Countries that do not
currently address the needs o people who inject drugs in their national AIDS
strategies should take immediate steps to rectiy this. Governments must urgently
commit major new resources to comprehensive evidence-inormed prevention
programmes or people who inject drugs and intensiy eorts to increase the scale o
HIV testing, opioid substitution therapy needle distribution and condom use.
Fig. 2.2
hIV sndin n injt drus18 low- and middle-income countries with available data, latest year available
35
20
25
30
15
5
10
0
International
Domestic public
2008 or 2009
MillionsofUSdollars
2006 or 2007 2010 or 2011
People who inject drugs
Source: 2012 country progress reports (www.unaids.org/cpr).
7/29/2019 20121120 UNAIDS Global Report 2012 En
44/11042
UNAIDS
Te world has embarked on an historic eort to end new HIV inections among
children and reduce the number o women living with HIV who die rom
pregnancy-related causes. Stakeholders have joined together to develop the Global
Plan towards the elimination o new HIV inections among children by 2015
and keeping their mothers alive (1). In 2011, the world made additional progress
in advancing towards the 2015 goal, generating signicant condence in the
easibility o eliminating new inections among children by 2015.
The NUMbeR of chIlDReN Newly INfecTeD wITh hIV
coNTINUeS To DeclINe
In 2011, 330 000 [280 000390 000] children acquired HIV inection. Tis represents
a 43% decline since 2003 (when 560 000 [510 000650 000] children became newly
inected) and a 24% drop since 2009 (when 430 000 [370 000490 000] children
acquired HIV inection).
More than 90% o the children who acquired HIV inection in 2011 live in sub-
Saharan Arica. Tere, the number o children newly inected ell by 24% rom 2009
to 2011. Te number o children acquiring HIV inection also declined signicantly
in the Caribbean (32%) and Oceania (36%), with a more modest decline in Asia
(12%). Declines have also been modest in Latin America (24%), Eastern Europe and
Central Asia (13%). However, these three regions had already signicantly reduced
the numbers o children newly acquiring HIV inection. Te Middle East and North
Arica is the only region that has yet to see a reduction in the number o children
newly inected.
In countries with generalized epidemics that account or the overwhelming majority
o the children newly inected, major gains have occurred during the past decade.
In six countries (Burundi, Kenya, Namibia, South Arica, ogo and Zambia), the
number o children newly inected declined by 4059% rom 2009 to 2011. In 16
additional countries, declines o 2039% occurred during the same period.
3 HIV InFectIon AMong
cHIldren And KeePIng tHeIrMotHers AlIVe
409 000In t tr ars 2009 t
2011, antirtrvira rais
rvntd 409 000 idrn rm
auirin hIV intin in
- and midd-inm
untris.
7/29/2019 20121120 UNAIDS Global Report 2012 En
45/11043
2012 GLOBAL REPORT
Table 3.1
prnta dras tn 2009 and 2011 in t numr idrn (014 ars d)auirin hIV intin in untris it nraid idmis
Sources: UNAIDS estimates.
Inrasd
Angola
Congo
Equatorial Guinea
Guinea-Bissau
119%
Benin
Burkina Faso
Central African RepublicChad
Djibouti
Eritrea
Gabon
Mozambique
Nigeria
South Sudan
United Republic of Tanzania
2039%
Botswanaa
Cameroon
Cte d'Ivoire
Ethiopia
Ghana
Guinea
Haiti
LesothoLiberia
Malawi
Papua New Guinea
Rwanda
Sierra Leone
Swaziland
Uganda
Zimbabwe
4059%Burundi
Kenya
Namibia
South Africa
Togo
Zambia
Progress has not been universally apparent, however, underscoring the importance
o intensied action to achieve the global goal o zero new inections among
children by 2015. In 11 countries, the number o children newly inected has
declined modestly by 119% since 2009, and this has actually increased in our
countries: Angola, Congo, Equatorial Guinea and Guinea-Bissau (able 3.1).
Although reductions in the number o adults acquiring HIV inection are helping
to lower childrens risk o acquiring HIV, recent gains in bringing antiretroviral- and
inant eedingbased prevention services to scale are primarily responsible or the
sharp reductions in the number o children newly inected. From 2009 to 2011,
antiretroviral prophylaxis prevented 409 000 children rom acquiring HIV inection
in low- and middle-income countries.
HIV inection among children and keeping their mothers alive
a Note: the baseline year for the Global Plan is 2008. Some countries had already made important progress in reducing the number of new HIV infections amongchildren in the years before 2009, notably Botswana which, by 2009, already had 92% coverage of antiretroviral medicines among pregnant women. In countries
with high coverage, further declines in HIV infections among children are harder to achieve.
7/29/2019 20121120 UNAIDS Global Report 2012 En
46/11044
UNAIDS
Fig. 3.1
prnta rnant mn ivin it hIV rivin tiv antirtrvira rimns rrvntin mtr-t-id transmissin, rin, 2010 and 2011
Coverage for Eastern Europe and Central Asia is not reported because the data have not been completely validated.
Sources: 2012 country progress reports (www.unaids.org/cpr) and UNAIDS estimates.
100
80
60
40
20
0
2010
2011
Middle East andNorth Africa
South andSouth-East Asia
East Asia andOceania
Caribbean Sub-SaharanAfrica
Latin America Low- and middle-income countries
%
A blUepRINT To elIMINATe New hIV INfecTIoNS AMoNg
chIlDReN
Four key actions are recommended to reduce the number o children acquiring
HIV inection: (1) strengthen primary HIV prevention services to ensure that
reproductive-age women and their partners avoid HIV inection, (2) take steps(such as providing contraceptives and counselling) to meet the unmet need
or amily planning among women living with HIV, (3) provide HIV testing,
counselling and antiretroviral medicines in a timely manner to pregnant women
living with HIV to prevent transmission to their children and (4) ensure proper
and timely HIV care, treatment and support or women living with HIV, children
living with HIV and their amilies.
With respect to preventing children rom acquiring HIV inection, the state o
the art is rapidly evolving, as new evidence emerges regarding the most eective
methods o reducing the risk o transmission. Similarly, countries need to adaptexisting systems and approaches as new evidence becomes available. Critical
decisions include whether to maintain lielong triple antiretroviral therapy or
pregnant women living with HIV who initiate treatment at CD4 counts above
350 per ml, whether to include eavirenz in combination regimens or pregnant
women and the type and duration o recommended inant-eeding practices to
maximize prevention benets or the child.
7/29/2019 20121120 UNAIDS Global Report 2012 En
47/11045
2012 GLOBAL REPORT
Table 3.2
prnta rnant mn rivin antirtrvira rimns (udin sin-dsnvirain) r rvntin mtr-t-id transmissin in untris it a nraididmi, 2011
Sources: 2012 country progress reports (www.unaids.org/cpr) and UNAIDS estimates.
7/29/2019 20121120 UNAIDS Global Report 2012 En
48/11046
UNAIDS
Te percentage o pregnant women and inant pairs receiving antiretroviral
medicines to prevent mother-to-child transmission exceeds 50% in most countries
with generalized epidemics and available data. Coverage o antiretroviral regimens
exceeds 75% in 8 countries with generalized epidemics, with an additional 13
countries reporting coverage rom 50% to 74% (able 3.2).
In breasteeding populations, providing antiretroviral medicines to the mother
or the inant during breasteeding is also critically important or avoiding
transmission to the child (2). Among the 21 Global Plan priority countries in
sub-Saharan Arica, the proportion o pairs o women living with HIV and inants
provided with prophylaxis during breasteeding has increased since 2009.
Fig. 3.2 illustrates transmission rates among children in dierent sub-regions
o sub-Saharan Arica. As the results demonstrate, some regions have made
strong progress: southern Arica, the subregion in sub-Saharan Arica with the
highest coverage o services to prevent children rom acquiring HIV inection,
has achieved the lowest post-breasteeding transmission rate (17%). Te central
and western Arica subregion, by contrast, still has transmission rates close to
30% because o lower service coverage, especially or prophylaxis during the
breasteeding period.
Fig. 3.2
Trnds in mtr-t-id transmissin rats surin in su-Saaran Aria, 20002011
Source: UNAIDS estimates.
Western Africa
Central Africa
Eastern Africa
Southern Africa
prcnta
gofhIV-xosdcildrninfctd
0
2003 2011 2015
40
7/29/2019 20121120 UNAIDS Global Report 2012 En
49/11047
2012 GLOBAL REPORT
For the children who do become inected with HIV, international guidelines
recommend that all children younger than two years start immediately on
antiretroviral therapy, whereas older children ollow dierent guidelines based on
their CD4 levels (3). In 2011, only 28% [2531%] o children 014 years old who
were eligible were receiving the lie-saving medicines. Depending on the age o the
child when inected, this could mean death within less than one year (4).
Ensuring treatment access or mothers living with HIV benets not only mothers
themselves but also their children, since studies indicate that children whose
mothers die also have an increased risk o death regardless o the childs HIV
status. Te percentage o treatment-eligible pregnant women living with HIV who
are receiving antiretroviral therapy or their own health in 2011 was 30% [27
32%] lower than the estimated coverage or all adults eligible or antiretroviral
therapy (according to WHO guidelines) o 54% [5159%]. Qualitative research is
needed to determine why, despite higher levels o access to health care, pregnant
women are not starting, or being reported to start, antiretroviral therapy. Recent
estimates suggest that pregnancy-related deaths among women living with HIV
have declined rom 46 000 in 2005 to an estimated 37 000 in 2010. More eort is
needed to ensure that pregnant women tested or HIV during antenatal care are
also tested or eligibility or antiretroviral therapy.
Since pregnant women living with HIV have a much higher risk o developing
B, B screening, prevention and inection control are integral components
o the package o care or eliminating mother-to-child transmission. Te risk
o developing active B is more than 10 times higher among pregnant women
living with HIV than among HIV-negative pregnant women. In addition, B
is associated with a range o extremely poor obstetric and perinatal outcomes,
including more than double the risk o HIV transmission to the unborn child, a
2.2- to 3.2-old increased risk o maternal mortality and a 3.4-old increased risk
o inant mortality(5). Since antiretroviral therapy reduces the risk o B by 65%
irrespective o CD4 count, combining early antiretroviral therapy with regular
B screening at each health visit helps ensure that eligible mothers are provided
isoniazid preventive treatment or early treatment or active B, giving both
mother and child a much better chance o survival.
Pregnant women living with HIV in humanitarian crisis settings are at particular
risk. o reach the objective o no child born with HIV inection and keeping their
mothers alive, humanitarian actors should scale up prevention services and ensure
that orcibly displaced women have access to HIV prevention services, treatment,
care and support.
HIV inection among children and keeping their mothers alive
30%tReAtmeNt coVeRAge
on 30% ii rnant
mn r rivin
antirtrvira tra r tir
n at in 2011, mard
it 54% r a ii aduts.
7/29/2019 20121120 UNAIDS Global Report 2012 En
50/11048
UNAIDS
NATIoNAl polIcIeS NeeD STReNgTheNINg
Among the 22 priority countries included in the Global Plan,1 21 have developed
national targets or preventing children rom becoming newly inected with HIV
and have aligned their national strategies with the elements o the Global Plan.
However, available evidence reveals persistent shortcomings in policy rameworksand clinical practices in many o these countries. In 2011, or example, 32
countries (including 12 countries with a high burden o HIV inection) reported
they were still providing some pregnant women with suboptimal single-dose
nevirapine regimens or preventing children rom acquiring HIV inection.
Although breasteeding is the norm throughout most o sub-Saharan Arica and
many other parts o the world, only 10 o 43 countries in this region reported
the number o breasteeding women or inants who were receiving antiretroviral
prophylaxis during breasteeding. Tese disappointing results may be partly
explained by weak reporting mechanisms, but they are also likely to reect
challenges that countries are experiencing in linking breasteeding women with
needed services and support at both the acility and community levels.
National and global leadership in the quest to eliminate new inections among
children also needs to improve. Tirteen o the 22 Global Plan priority countries
reported on trends in spending on services to prevent children rom becoming
newly inected with HIV between 2008 and 2010. Te resources dedicated to
programmes to prevent children rom acquiring HIV inection has increased in
some countries (Botswana, Burundi, Cameroon, Ghana and Kenya), but declines
in unding (Angola, Chad and Namibia) or inconsistent spending patterns (the
Democratic Republic o the Congo, India, Lesotho and Nigeria) are reported
elsewhere, according to reported AIDS spending data.
elIMINATINg New hIV INfecTIoNS AMoNg chIlDReN AND
KeepINg TheIR MoTheRS AlIVe: TowARDS 2015
Achieving 57% coverage o services to prevent children rom acquiring HIV inection
represents a major accomplishment. However, reaching the global goal o eliminating
new HIV inections among children by 2015 will require not only accelerated eorts to
bring services to prevent children rom acquiring HIV inection to scale but also steps
to ensure that all programmatic elements o the Global Plan are ully implemented. In
particular, reaching global goals will be impossible without preventing reproductive-
age women rom acquiring HIV inection and enabling women living with HIV to
make decisions about their reproductive lie. Te most eective prophylactic regimens
must be used, and prevention eorts must extend beyond the antenatal period to
1 Te Global Plan priority countries include: Angola, Botswana, Burundi, Cameroun, Chad, Cte dIvoire, Democratic Republic o the Congo, Ethiopia, Ghana, India, Kenya, Lesotho, Malawi, Mozambique,Namibia, Nigeria, South Arica, Swaziland, Uganda, United Republic o anzania, Zambia and Z imbabwe.
7/29/2019 20121120 UNAIDS Global Report 2012 En
51/11049
2012 GLOBAL REPORT
encompass the duration o breasteeding as well (6). Early diagnosis and treatment
will be critical or improving the survival o children exposed to HIV and or ensuring
high-quality programmes. Partners will need to collaborate to retrain nurses and
ensure that all clinical settings have access to essential medicines.
Intensied eorts are needed to deliver timely, high-quality treatment and care to women
living with HIV. An estimated 70% [6873%] o pregnant women with CD4 counts
below 350 per ml are not receiving antiretroviral therapy a pattern that undermines
womens health as well as global eorts to prevent transmission to their children.
Growing evidence indicates the wisdom o continuing to provide mothers
living with HIV with the same combination regimens they take as prophylaxis
during pregnancy or the remainder o their lives (Option B+). Tis approach
has the potential to reduce transmission rates or uture births, lower the odds
o transmission to sexual partners, improve maternal survival and promote
simplied treatment regimens (7). It is essential that this be implemented with the
inormed consent o the women concerned and in a rights-based manner.
Integrating comprehensive prevention and antiretroviral services with maternal,
neonatal and child health services will improve the eciency and eectiveness
o all interventions. By packaging services, women are more likely to obtain
the services they require and service eciency will be enhanced (8). Service
integration is especially important in countries with generalized HIV epidemics,
since HIV care is a substantial burden or already weak health care systems.
Additional eorts are also needed to minimize social and structural impediments
to scaling up. Community programmes that mentor mothers, support disclosure,
promote the involvement o men and boys and reduce stigma and discrimination
are all critical to promote access to essential services and retain amilies in care.
In addition, even in countries that have reached high levels o service coverage,
concerted eorts are needed to reach the most marginalized and vulnerable
populations, such as women who use drugs, women who sell sex, women in
prison, illegal migrants and ethnic minorities. Te marginalized groups, who are
ofen missed by mainstream maternal and child health services, experience rates
o HIV transmission rom mother to child that are nearly 2.5 times higher than
that o the general population (9).
Involving aected communities, innovation and commitment will be required
to alleviate the stigma that would deter women living with HIV and vulnerable
women rom attending antenatal care. Recognizing the unique opportunity to
eliminate new HIV inections among children by 2015, national and international
partners also need to ensure that competing health priorities do not crowd out
essential support or HIV prevention services.
HIV inection among children and keeping their mothers alive
2.5cidrn mtrs in
marinaid uatins
rin hIV transmissin
nar 2.5 tims ir tan in
t nra uatin.
7/29/2019 20121120 UNAIDS Global Report 2012 En
52/11050
UNAIDS
4 treAtMent
Te rapid expansion o antiretroviral therapy one o the most remarkable
achievements in recent public health history continued in 2011. More people
initiated antiretroviral therapy in 2011 than in any previous year, with the number o
people living with HIV receiving treatment rising by 21% compared with 2010 based
on data rom country progress reports. Expanding coverage is saving lives, since about
hal o the people with a CD4 count less than 350 per ml, the current threshold or
initiating treatment, would be expected to die within two years i they did not get
antiretroviral therapy. Tis accelerating pace needs to be sustained i the world is to
achieve the goal o reaching 15 million people with HIV treatment by 2015.
pRoMISINg TReNDS IN TReATMeNT coVeRAge
Antiretroviral therapy reached 8 million people by the end o 2011 a 20-old increase
since 2003 (Fig. 4.1). Since 1995, antiretroviral therapy has added 14 million lie-years
in low- and middle-income countries, including 9 million in sub-Saharan Arica.
Fig. 4.1
Numr rivin antirtrvira tra in - and midd-inm untris, rin, 20022011
Source: 2012 country progress reports (www.unaids.org/cpr).
9
8
7
6
5
4
3
2
1
0
End 2002 End 2003 End 2004 End 2005 End 2006 End 2007 End 2008 End 2009 End 2010 End 2011
Millions
North Africa and the Middle East
Europe and Central Asia
East, South and South